BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2164348)

  • 1. c-myc oncoprotein in bronchial carcinoma: expression in all major morphological types.
    Gosney JR; Field JK; Gosney MA; Lye MD; Spandidos DA; Butt SA
    Anticancer Res; 1990; 10(3):623-8. PubMed ID: 2164348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical study of RAS oncoprotein in cytologic specimens of primary lung tumours.
    Koutselini H; Kappatou G; Yiagnisis M; Field JK; Spandidos DA
    Anticancer Res; 1990; 10(3):597-603. PubMed ID: 2164347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
    Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
    Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of ras p21 and myc p62 oncoproteins in small cell and non small cell carcinoma of the lung.
    Spandidos DA; Zakinthinos S; Petraki C; Sotsiou F; Yiagnisis M; Dimopoulos AM; Roussos C; Field JK
    Anticancer Res; 1990; 10(5A):1105-14. PubMed ID: 2173469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of c-myc oncoprotein in non-small-cell lung carcinoma: comparison with immunohistochemical results.
    De Santis L; Mangili F; Sassi I; Di Rocco M; Rossi C; Cantaboni A
    Anal Cell Pathol; 1995 Apr; 8(3):247-57. PubMed ID: 7547497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 expression as an apoptotic index in non small cell lung carcinomas.
    Kalogeraki A; Kozoni V; Zoras O; Tamiolakis D; Panayiotides J; Charakidas A; Chalkiadakis G; Bouros D; Stathopoulos E; Delides GS
    In Vivo; 2001; 15(1):53-6. PubMed ID: 11286130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expression of the c-myc oncoprotein correlates with poor prognosis in head and neck squamous cell carcinoma.
    Field JK; Spandidos DA; Stell PM; Vaughan ED; Evan GI; Moore JP
    Oncogene; 1989 Dec; 4(12):1463-8. PubMed ID: 2687767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
    Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
    Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen-receptor-related protein p29 in primary nonsmall cell lung carcinoma: pathologic and prognostic correlations.
    Vargas SO; Leslie KO; Vacek PM; Socinski MA; Weaver DL
    Cancer; 1998 Apr; 82(8):1495-500. PubMed ID: 9554526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES; Harclerode D; Gondo M; Stephenson M; Brown RW; Younes M; Cagle PT
    Mod Pathol; 1997 Feb; 10(2):142-8. PubMed ID: 9127320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
    Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
    Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
    Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
    Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic pitfalls in bronchopulmonary tumors].
    Thivolet-Béjui F
    Arch Anat Cytol Pathol; 1997; 45(5):249-53. PubMed ID: 9588034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchogenic carcinoma. A study of 109 cases.
    Jain NK; Madan A; Sharma TN; Agnihotri SP; Saxena A; Mandhana RG
    J Assoc Physicians India; 1989 Jun; 37(6):379-82. PubMed ID: 2556362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anamnesis, symptoms and prognosis of 767 bronchial cancers of different histologic types].
    Bloedner CD; Dinkel M; Büttner M
    Prax Klin Pneumol; 1988 Jan; 42(1):17-24. PubMed ID: 2832840
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer.
    Chyczewski L; Nikliński J; Chyczewska E; Laudański J; Furman M
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():162-72. PubMed ID: 9337534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic lesions in non-neoplastic bronchial mucosa associated with bronchial carcinomas.
    Kayser K; Hagemeyer O; Runtsch T
    Zentralbl Pathol; 1991; 137(5):425-9. PubMed ID: 1666300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of bcl-2 in small cell lung carcinoma cells.
    Ikegaki N; Katsumata M; Minna J; Tsujimoto Y
    Cancer Res; 1994 Jan; 54(1):6-8. PubMed ID: 8261463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.